6 Einträge gefunden

1. Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancers

   1. Rades, Dirk
   2. Seidl, Daniel
   3. Janssen, Stefan
   4. Strojan, Primoz
   5. Karner, Katarina
   6. Bajrovic, Amira
   7. Hakim, Samer G

   2017 - Forschungsinformationssystem des UKE
2. Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?

   1. Rades, Dirk
   2. Seidl, Daniel
   3. Janssen, Stefan
   4. Bajrovic, Amira
   5. Hakim, Samer G
   6. Wollenberg, Barbara
   7. Karner, Katarina

   2016 - Forschungsinformationssystem des UKE
3. Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks

   1. Rades, Dirk
   2. Strojan, Primoz
   3. Seidl, Daniel
   4. Janssen, Stefan
   5. Bajrovic, Amira
   6. Kazic, Nadja
   7. Hakim, Samer G

   2016 - Forschungsinformationssystem des UKE
4. Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?

   1. Rades, Dirk
   2. Seidl, Daniel
   3. Janssen, Stefan
   4. Bajrovic, Amira
   5. Hakim, Samer G
   6. Wollenberg, Barbara
   7. Schild, Steven E

   2016 - Forschungsinformationssystem des UKE
5. Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer

   1. Seidl, Daniel
   2. Janssen, Stefan
   3. Strojan, Primoz
   4. Bajrovic, Amira
   5. Schild, Steven E
   6. Rades, Dirk

   2016 - Forschungsinformationssystem des UKE
6. Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers

   1. Rades, Dirk
   2. Seidl, Daniel
   3. Janssen, Stefan
   4. Bajrovic, Amira
   5. Karner, Katarina
   6. Strojan, Primoz
   7. Schild, Steven E

   2016 - Forschungsinformationssystem des UKE - frei zugänglich